SPCX's Lockup Day Crash After Earnings Beat - Falling Knife or Falling Opportunity?

SpaceX reported a blowout first quarter as a public company on Tuesday - $7.8 billion in revenue versus a $6.8 billion consensus estimate, and EPS of -$0.09 that beat the -$0.23 expectation. Revenue jumped 92% year-over-year. The stock fell 7.5% in after-hours trading.

Then yesterday - the day before 911.5 million shares become eligible to sell after the first lockup expiration - the stock dropped another 13.6%, closing at $108.27 on 208.5 million shares of volume. That's $23.3 billion of turnover in a single session. The stock is now roughly 52% below its $225.64 intraday high and approximately 20% below its $135 IPO price.

The broader media chorus has been nearly unanimous: this lockup is going to wreck the stock. Everyone is selling into it. The float is too thin. Supply will crush demand.

The headline fear sounds mechanical and obvious. But the mechanical fear doesn't survive contact with the numbers.

Let's start with the question most investors aren't asking: has SpaceX's business gotten 52% worse since the stock peaked? The answer is no. The Q2 revenue beat tells you that much. The 92% year-over-year growth rate tells you even more. Starlink, the cash engine at the center of this company, has 10.3 million subscribers across 164 countries - up 105% from a year ago - and generated $4.4 billion in operating income on $11.4 billion of revenue in fiscal 2025. That's real operating leverage: the satellite constellation cost is largely fixed, so every new subscriber is nearly pure margin.

The AI segment - xAI, Grok, and the X platform - is still bleeding. It lost $6.4 billion on operating income in fiscal 2025 and chewed through $12.7 billion in capital expenditures. That's the part that makes this company look like a capex black hole. But it's the same pattern you see in every infrastructure buildout before it matures. The question isn't whether xAI is spending. The question is whether the AI orbital compute platform SpaceX is building has a path to returns - and the market's current verdict, at a $1.43 trillion market cap, is yes.

Now let's talk about the lockup itself, because the way it's being described is doing the stock a disservice.

The 911.5 million shares unlocking today are not new shares. This isn't dilution. These shares already exist, held by employees and early investors who acquired them at a fraction of the IPO price. What's changing is liquidity, not ownership structure. And yes, some of those holders will sell. The economics are irresistible: employees who bought in at private valuations well below $135 are sitting on enormous paper gains, and a fraction of them will diversify, pay taxes, or leave for a competitor.

But the market is treating the full 911.5 million shares as if they're all going to the street tomorrow. That's not how lockups work. Only about 20% of the 180-day eligible block unlocks today, roughly 182 million shares. And even that 20% isn't a guarantee of selling - it's a permission slip. The staggered schedule was designed to prevent exactly the kind of supply shock the media is hyping. The float jumps from below 5% to roughly 12% today. That's a big increase, but it's not the cliff people are describing. The real supply waves come later: Q3 unlock in November, the full 180-day expiry in December, and Musk's 6.4 billion shares in June 2027. Musk's stake has no early-release provision. He stays locked the longest.

Here's the part that matters most for the risk/reward setup. The stock is down 52% from its high in less than two months. Revenue is growing at a pace that would be exceptional for any mature company, let alone a 24-year-old firm that's only just gone public. Gross margins are at 51.9%. The balance sheet carries $93.5 billion in cash against $65.6 billion in debt - a net cash position of roughly $60.7 billion. The current ratio is 511.5%. This is not a company teetering on solvency. It's a company that's spending aggressively on infrastructure while sitting on a fortress balance sheet.

The valuation, of course, is where the skepticism has real legs. At 61.9 times trailing sales and negative earnings, the multiple demands that the AI story delivers. That's a fair concern. The capex run rate - $43.3 billion trailing twelve months, with some analysts projecting $118 billion by 2028 - is enormous. If the AI orbital compute bet doesn't materialize, those multiples are unsustainable.

But the market has arguably baked in a doomsday narrative that goes beyond what the fundamentals justify. AInvest's aggregate signal still labels SPCX a Buy, which suggests the sell-side hasn't flipped on the underlying thesis despite the price carnage. The composite analysis rating of 2.35 out of 10 doesn't scream conviction either, but it's not a sell signal - it's a reflection of the stock's recent action, not a judgment that the business has broken.

From a price-action standpoint, the stock is flashing oversold signals. The RSI-14 sits at 37.9, approaching the 30-level where selling exhaustion typically becomes visible. The MACD line is deeply negative at -10.5, confirming the downtrend but also setting up the kind of divergence that often precedes a bounce when the trend has run too far, too fast. The average true range - a measure of daily volatility - is $11.13, meaning normal swings on this stock are wide enough that the current move, while dramatic, isn't structurally unusual for this issue.

The real risk here isn't the business. The real risk is that this is a stock whose early price was set by scarcity - a 4.9% float competing against enormous IPO demand - and is now undergoing the violent process of discovering what its fair price is when the float actually resembles a normal public company. That discovery can be painful, and it can take months. The next unlock events in late August, September, October, and November will each retest the setup.

But if you're looking at this from the other direction, the setup is increasingly attractive. A company growing revenue at 66% quarter-over-quarter, with a 52% gross margin, $60 billion in net cash, and a dominant position in launch and satellite broadband, trading at approximately 20% below its IPO price after the market's initial euphoria has been fully squeezed out - that's a mispricing, not a warning.

I think investors need to separate the lockup mechanics from the business fundamentals. The lockup creates supply overhang, yes. But the sellside narrative assumes every eligible share becomes a sold share, every employee becomes a leaver, and every early investor loses faith. That's the fear, not the evidence.

My posture here is not to chase the stock today - the 13.6% drop on August 5 with 208 million shares of volume tells you selling isn't done. But the risk/reward is turning from "stay away" to "watch for exhaustion." I'd reassess the sell thesis if the next unlock events continue to drive the stock below $95, which would suggest the scarcity premium collapse is deeper than the earnings justify. But a bounce from here, once the lockup selling thins out and the market digests that Q2 was a legitimate beat, seems increasingly likely.

Don't let the headline fear about supply and dilution blind you to the fact that SpaceX just reported its first quarter as a public company with results that handily exceeded expectations. The lockup is a supply event, not a thesis event. And the thesis - 92% revenue growth, a Starlink cash engine, and an AI infrastructure bet backed by a fortress balance sheet - remains largely intact.